Ioversol API Market, Global Outlook and Forecast 2024-2031

Report ID: 1785900 | Published Date: Jan 2025 | No. of Page: 71 | Base Year: 2024 | Rating: 4.8 | Webstory: Check our Web story

Ioversol. Mainly used for various vascular radiography examinations, including: cerebral angiography, peripheral arteriography, visceral artery, renal artery and aortic angiography, cardiovascular angiography including coronary angiography.
This report contains market size and forecasts of Ioversol API in global, including the following market information:
Global Ioversol API Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global Ioversol API Market Sales, 2017-2022, 2023-2028, (Tons)
Global top five Ioversol API companies in 2021 (%)
The global Ioversol API market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period 2022-2028.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Original Drug Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Ioversol API include Guerbet Group, Brother Technology and Stellite, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Ioversol API manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Ioversol API Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (Tons)
Global Ioversol API Market Segment Percentages, by Type, 2021 (%)
Original Drug
Generic Drug
Global Ioversol API Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (Tons)
Global Ioversol API Market Segment Percentages, by Application, 2021 (%)
Hospitals
Clinics
Global Ioversol API Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (Tons)
Global Ioversol API Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Ioversol API revenues in global market, 2017-2022 (Estimated), ($ millions)
Key companies Ioversol API revenues share in global market, 2021 (%)
Key companies Ioversol API sales in global market, 2017-2022 (Estimated), (Tons)
Key companies Ioversol API sales share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
Guerbet Group
Brother Technology
Stellite

Frequently Asked Questions
Ioversol API Market report offers great insights of the market and consumer data and their interpretation through various figures and graphs. Report has embedded global market and regional market deep analysis through various research methodologies. The report also offers great competitor analysis of the industries and highlights the key aspect of their business like success stories, market development and growth rate.
Ioversol API Market report is categorised based on following features:
  1. Global Market Players
  2. Geopolitical regions
  3. Consumer Insights
  4. Technological advancement
  5. Historic and Future Analysis of the Market
Ioversol API Market report is designed on the six basic aspects of analysing the market, which covers the SWOT and SWAR analysis like strength, weakness, opportunity, threat, aspirations and results. This methodology helps investors to reach on to the desired and correct decision to put their capital into the market.

Related Reports

Iopromide API Market

Iopromide is a new type of non-ionic hypotonic contrast agent, and animal experiments have shown  ... Read More